School of Medicine


Showing 11-20 of 85 Results

  • Che-Hong Chen

    Che-Hong Chen

    Senior Research Scientist - Basic Life, Chemical and Systems Biology Operations

    Current Role at StanfordSenior Research Scientist
    CEO, International ALDH2 STAR Research Consortium
    Director of China, Singapore, and Taiwan Outreach, Center for Asian Health Research and Education Center

  • Christopher T Chen, MD

    Christopher T Chen, MD

    Assistant Professor of Medicine (Oncology)

    BioDr. Chen is a board-certified, fellowship-trained specialist in oncology and hematology. He is also an Assistant Professor in the Division of Oncology in the Department of Medicine at Stanford University School of Medicine.

    Dr. Chen delivers comprehensive, compassionate care for patients in need of early drug development clinical trials and patients with gastrointestinal cancers. As a researcher, he leads the early drug development group and studies how tumor heterogeneity limits the clinical benefit of anticancer therapies in order to accelerate development of novel therapeutic strategies. Dr. Chen’s work has appeared in the New England Journal of Medicine, JAMA, Journal of Clinical Oncology, Science Advances, Journal of Oncology Practice, and Health Services Research.

    Dr. Chen attended Harvard College, where he graduated summa cum laude and Phi Beta Kappa in molecular biology. He went to medical school at Washington University in St. Louis on a full-tuition merit scholarship, graduating with Alpha Omega Alpha honors, and did his residency training in internal medicine at Massachusetts General Hospital and hematology/oncology fellowship in the combined Harvard Dana-Farber Cancer Institute/Massachusetts General Hospital program. As a fellow, he received the NIH T-32 Ruth L. Kirchstein-National Service Research Award in Cancer Biology for his work exploring the molecular structure of metastatic solid tumors.

    Dr. Chen is a member of the American Society of Clinical Oncology, European Society for Medical Oncology, and American Association for Cancer Research.

  • Gerald Crabtree

    Gerald Crabtree

    David Korn, MD, Professor of Pathology and Professor of Developmental Biology

    Current Research and Scholarly InterestsChromatin regulation and its roles in human cancer and the development of the nervous system. Engineering new methods for studying and controlling chromatin and epigenetic regulation in living cells.

  • Neeladrisingha Das

    Neeladrisingha Das

    Postdoctoral Scholar, Radiation Physics

    BioNeel is a postdoc fellow in the Pratx lab at Stanford University. He is currently working on the role of radiotherapy in cancer cell death and the various mechanism involved in radio-induced cell death. Neel comes from a very small town in Odisha, India (Athgarh) and had schooling in his hometown. He had a keen interest in animal biology and started his B.S in Zoology at Gopabandhu Science College, Athgarh. Later he did his M.S in Zoology from Sambalpur University, Odisha, India. He carried out his doctoral studies at the Indian Institute of Technology Roorkee in the lab of Prof. Partha Roy. His main study was on the anti-cancer activity of various natural-based products and their mechanism of action. Neel is a trained cell and molecular biologist. His research interest includes- Cancer cell death mechanisms and developing therapeutics for cancer stem cells and metastasis.

  • Laura M.K. Dassama

    Laura M.K. Dassama

    Assistant Professor of Chemistry and of Microbiology and Immunology

    BioLaura Dassama is a chemical biologist who uses principles from chemistry and physics to understand complex biological phenomena, and to leverage that understanding for the modulation of biological processes. Her current research focuses on deciphering the molecular recognition mechanisms of multidrug transporters implicated in drug resistance, rational engineering and repurposing of natural products, and control of transcription factors relevant to sickle cell disease.

  • Shirit Einav

    Shirit Einav

    Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology

    Current Research and Scholarly InterestsOur basic research program focuses on understanding the roles of virus-host interactions in viral infection and disease pathogenesis via molecular and systems virology single cell approaches. This program is combined with translational efforts to apply this knowledge for the development of broad-spectrum host-centered antiviral approaches to combat emerging viral infections, including dengue, coronaviruses, encephalitic alphaviruses, and Ebola, and means to predict progression to severe disease.